DealBook Blog: $3 Billion Deal Reported for Drug Trial Firm
219523
Bain Capital and TPG Capital have agreed to buy Quintiles Transnational, one of the biggest managers of drug trials, for more than $3 billion, people briefed on the transaction told DealBook.
561496
The Swiss drug maker said it would start a tender offer to acquire Ventana Medical Systems for about $3 billion.
17093
ID Biomedical Corp. (IDB.TO: Quote, Profile, Research) (IDBE.O: Quote, Profile, Research) signed a 10-year US distribution deal for its Fluviral drug that could reap
356950
Consolidation in Europe's drugs   sector gathered steam on Thursday as Germany's Merck unveiled a   $13.3-billion deal to buy Europe's top biotech firm Serono, and   Denmark's Nycomed won the drugs unit of Altana.
518270
AMSTERDAM -- Schering-Plough Corp. agreed to buy Akzo Nobel NV's drug-making division Organon for $14.4 billion to gain the world's third-largest maker of birth-control pills and a stable of experimental medicines.
512814
Boston Scientific Corp. said yesterday it sold $8.3 million worth of its Taxus drug-coated cardiac stents per day this month, a record level the Natick medical-devices giant said demonstrates it has won back doctors' confidence after three recalls.
594254
Bain and TPG announced they will acquire One Equityâs stake in Quintiles Transnational, one of the biggest managers of drug trials, for an undisclosed amount.
464346
The drugmaker posted third-quarter net income of $1.53 billion as revenues increased by double digits, while lower  costs offset more spending on research and development.
665486
Its sale of a chemotherapy drug indicates it could recoup what it paid for its ESP assets.
359157
Schering-Plough Corp. paid $435 million in fines and pleaded guilty to criminal conspiracy charges to settle Justice Department accusations that it lied to the government about drug prices and improperly marketed cancer drugs for uses not approved by the Food and Drug Administration.
374604
The Swiss pharmaceuticals company said that it would pay $3.1 billion for Ventana Medical Systems.
673153
HARLINGEN, Texas -- Attorneys for Merck &amp; Co. want to see bank and cellphone records that could show the extent of a juror's financial relationship with a plaintiff who won a $32 million verdict against the drug company in the death of a 71-year-old man who took Vioxx.
565909
More than 3,000 former users of Merck & Co's  withdrawn Vioxx pain drug have already signed up to take part in a $4.85 billion settlement deal that a federal judge said on Friday was in the best interests of both sides.
507533
ID Biomedical Corp. IDB.TO IDBE.O  signed a 10-year U.S. distribution deal for its Fluviral drug  that could reap sales of $2.3 billion and help U.S. authorities  fill a flu vaccine shortage, the company said on Monday.
415354
British pharmaceutical group GlaxoSmithKline said it had agreed to pay the US Treasury about 3.1 billion dollars (2.44 billion euros) after settling out of court a long-running tax dispute.
25622
The German biotechnology company Paion and its American partner, Forest Laboratories, announced the outcomes of the trial of its drug, desmoteplase.
582652
Roche Holding AG, the world's biggest maker of diagnostic tests, offered to buy Ventana Medical Systems Inc. for about $3 billion as it expands screening to match patients with the right drugs.